Sleep-disordered Breathing and Perioperative Atrial Fibrillation in Cardiac Surgery
- Conditions
- Coronary Artery DiseaseElective Coronary Artery Bypass Grafting (CABG) SurgerySleep-disordered Breathing (SDB)Atrial Fibrillation
- Interventions
- Other: Stratification, no intervention
- Registration Number
- NCT02877745
- Lead Sponsor
- Michael Arzt
- Brief Summary
In patients undergoing elective coronary artery bypass grafting (CABG) surgery, coronary artery disease, sleep-disordered breathing (SDB), atrial fibrillation (AF) perioperative atrial fibrillation and complications will be assessed. The primary objective is to determine, whether SDB patients have a higher rate of Major Adverse Cardiac and Cerebrovascular Events (MACCE) within 30 days after surgery compared to those without SDB.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1200
- Patients undergoing elective CABG surgery at the Department of Cardiac and Thoracic Surgery, University Hospital Regensburg.
- Written informed consent
- Preoperative use of inotropes or intra aortic balloon pump
- Severe obstructive pulmonary disease
- Patients on oxygen therapy, nocturnal positive airway pressure support or mechanical ventilation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description SDB Stratification, no intervention apnea-hyponea index \>=15/hour no SDB Stratification, no intervention apnea-hyponea index \<15/hour
- Primary Outcome Measures
Name Time Method Major Adverse Cardiac and Cerebrovascular Events (MACCE) 30 days periprocedural and late myocardial infarction (MI), non-fatal stroke and transitory ischemic attack (TIA) as well as all-cause mortality
- Secondary Outcome Measures
Name Time Method postoperative atrial fibrillation (POAF) 30 days after CABG surgery assessed by ECG
Stroke within 1 year after CABG surgery assessed by questionnaire
MACCE within 1 and 2 years after CABG surgery assessed by questionnaire
Major pulmonary complications within 30 days as well as 1 and 2 years assessed by questionnaire
Trial Locations
- Locations (1)
Department of Internal Medicine II, University Hospital
🇩🇪Regensburg, Germany